Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-26

Clinical Trial Update: Switching Study From Warfarin to Rivaroxaban [Phase 1]

View source ↗

Summary

Phase 1 trial update examining switching from warfarin to rivaroxaban in patients with venous thrombosis; results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivaroxaban (rivaroxaban)
  • Warfarin (warfarin)

Snippet

Sponsor: Bayer | Conditions: Venous Thrombosis | Phase 1 | Status: COMPLETED | Results posted: 2012-04-26